BASIC STRUCTURE
The syndecan core protein consists of three domains; an extracellular domain ' ecto domain', a trans membrane domain and a cytoplasmic domain ( Figure 1 ).
Figure 1: Basic structure of Syndecan
The glycoaminoglycans attached to the extracellular domain of the core protein are responsible for the differential binding capabilities of the syndecans. 5 The ectodomain portion is equipped with sites for glycoaminoglycan attachment that can bind to several extracellular matrix molecules. It has a conserved site near the cell membrane where the syndecans are shed by proteolytic cleavage. This shedding process has a very important role in several pathophysiological events and is stimulated by different physiological mediators. The transmembrane domain is highly homologous and contains 24 to 25 amino acids. It contains regions for interaction with other membrane proteins and for localization to distinct membrane compartments. 6 The cytoplasmic domain or the intracellular domain plays an important role in initiating the intracellular signalling cascade and also in recruitment of the intracellular proteins to the cell membrane. It has two similar regions across the membranes of syndecan family that are separated by a central variable region that is specific for each family member. 7 The syndecans have distinct functions assigned to their core proteins and heparin sulfate chains. Therefore, syndecan function varies from extracellular cell adhesion domain organization and regulation of cellular proliferation and differentiation. 8 The heparin sulfate chain binds to various ligands that regulate cell behaviour during development. (Table  1 In keratinocytes, syndecan 1 is localized at the cell membrane especially, the suprabasal layers. 11 It has also been shown to bind various extracellular matrix proteins such as collagen, fibronectin and tenascin.
12 By binding to extracellular matrix molecules and growth factors. Syndecan 1 plays an important role in cell extra cellular matrix interactions and also in modulation of growth factor response. 13 It has been reported to mediate cell morphology regulation and maintenance of epithelial phenotype by affecting the organization of actin cytoskeleton. It also mediates cell proliferation and hence is activated during normal cell growth while on the other hand it is suppressed in abnormal cell proliferation.
14 There is a close association between fibroblast growth factor and syndecan -1 expression. Syndecan 1 expression is present during early embryonic development and has been localized on several developing epithelia for example epidermis, odontogenic and mammary epithelium. 15 It is considered as the earliest syndecan to be expressed during development. In a study by Sutherland et al in 1991, it has been shown that it initially appears at the four cell stage and later on, in all cells of the embryoblast in the blastocyst in mice. 10 After gastrulation, high expression is found in ectodermal and endodermal germ layers. It is also expressed in the mesenchyme during developmental stages especially, during the epithelial-mesenchymal interaction. During tooth odontogenesis, its expression is transiently present in the enamel epithelium and dental mesenchyme at bud stage and in stratium intermedium and stellate reticulum in bell stage. 16, 17 It provides stability to the extracellular matrix and help control chemical mediators in wound healing process 18 . It is increased in proliferating keratinocytes and in endothelial cells of developing capillaries within the granulation tissue. 6 Syndecan-1 acts as a matrix receptor due to its binding to different extracellular matrix molecules through its heparan sulfate chains extracellularly and contacting the cytoskeleton via its cytoplasmic domain intracellulary. Syndecan-1 expression is down regulated in tumorigenesis therefore, tumor cells with decreased syndecan-1 expression lose cell surface molecules that bind them to each another and to the extracellular matrix. 19 It has been suggested that syndecan-1 is removed from the cell surface by a mechanism called "the ectodomain shedding". 20 Through this process, syndecan-1 gets converted from a membrane bound cell surface molecule to a diffusible and soluble mediator, allowing this molecule to participate in various autocrine and paracrine signaling actions. The soluble syndecan-1 molecule retains its ability to bind different ligands such as FGF. 21 Enzymatic degradation of syndecan-1 converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF. In addition to the core protein shedding, the heparin sulfate chains of syndecan-1 can also be degraded by the enzymatic activity of heparanase . 22 Syndecan-1 is normally absent in the stromal cells though an increased expression in the stromal (fibroblasts and myofibroblasts) component of the neoplastic tissues has been reported. This stromal expression has been associated with poor prognosis in gastric, ovarian, breast, and head and neck cancers. [23] [24] [25] Various studies have indicated that syndecan-1 may enhance tumor growth by facilitating angiogenesis. 26 Syndecan-1 expression is reduced or lost in carcinoma cells, as compared with their normal counterparts that enables the cells to detach and invade. This loss of expression may be an early event that contributes to neoplastic progression. 23 In potentially premalignant disorders, such as oral epithelial dysplasia, its expression decreases as compared with normal oral stratified squamous epithelium. Therefore, syndecan-1 has been suggested as a marker for dysplastic changes. 27, 28 Ro et al (2006) reported that reduction of syndecan-1 expression correlated with increased tumor size and invasion in squamous cell carcinomas of the tongue. 29 Muramatsu et al (2008) examined the expression of syndecan-1 in oral cancer cell lines and found that reduction of syndecan-1 led to higher cell proliferation. 30 Syndecan-1 expression has been found to be reduced in odontogenic cysts and tumors when compared to normal cells of tooth buds. BolognaMolina et al. (2008) reported decreased expression of syndecan-1 in solid ameloblastoma compared to the unicystic ameloblastoma. 31 In another study, syndecan-1 expression when compared among peripheral, desmoplastic ameloblastomas and ameloblastic carcinoma, syndecan-1 expression was found to be decreased in ameloblastic carcinoma compared to other ameloblastomas. 32 Similarly, loss of syndecan-1 expression appears to correlate with poor prognosis in stomach, breast, and head and neck neoplasms. 25, 29, 33, 34 
Syndecan 2
It is termed as 'fibroglycan' as it is mainly produced by mesenchymal cells. It is predominantly expressed during embryonenesis. 35 Although its role in adult tissues has not been fully established, recent studies suggest its involvement in regulation of TGFβ signalling. TGFβ binds to the β glycan, which is transferred to the type II receptors that undergo autophosphorylation. 36 The phosphorylated type I and type II receptor complexes then engage in downstream cellular signalling. Betaglycan binds to the synectin that helps in retaining them on the cell surface, thus, preventing degradation. Synectin also binds to syndecan 2. Increase in the syndecan protein increases the type I and type II TGFβ receptor expression and decreases β glycan. This decrease in β glycan expression leads to deregulated activity of type I/ II TGFβ receptor complex.
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Syndecan 3
It is the largest syndecan in mammals which comprises of both heparin sulfate and chondroitin sulfate chains. It is also called 'neural syndecan' although its expression is seen in some stratified epithelia and differentiating cartilage. 38 It plays an important role in regulation of the skeleton muscle development. Its level has been shown to be increased during developing limb bud and totally absent in adult skeleton muscle. The skeleton muscle myoblasts are held in undifferentiated state until they receive signals for further differentiation. 39 These signals are mediated by specific growth factors such as FGF2, HGF, TGFβ. It also appears to be involved in regulation of Hh signalling activity that plays an important role in embryogenesis and differentiation. One of the mammalian family of Hh member is 'Indian Hh' which is produced by prehypertrophic chondrocytes and regulates chondrocyte differentiation. 
Syndecan -4
It is the smallest syndecan and most extensively studied member of the syndecan family. It is also called 'amphiglycan' as it is expressed both by the epithelial and fibroblastic cells. 41 It has a number of activities including cell adhesion, migration, proliferation endocytosis and mechanotransduction. It interacts with numerous heparin binding growth factors like fibroblast growth factors, vascular endothelial growth factors and platelet derived growth factors. Through the binding of these factors, syndecan-4 is able to organise their distribution in the extracellular space. Extracellular signalling of syndecan-4 is mediated by cleavage and shedding of its extracellular domain. In extracellular matrix, its binding with tenascin C, leads to matrix contraction thus playing an important part in wound healing. Syndecan-4 along with integrins, act as mediators of focal adhesion formation. It activates ADP ribosylation factor-6 which is involved in membrane trafficking, actin cytoskeletal remodelling and cell motility. It has also been suggested to function as sensors of extracellular stress that are capable of transmitting mechanical force into signalling events. Another function of syndecan 4 is activation of PKCα in absence of Ca + ions. Colocalization of these proteins in focal adhesion suggests a role in cell adhesion and stress fibre formation. 42 Syndecan-4 up regulation has been noted in hepatocellular carcinomas and malignant mesotheliomas and such over-expression may be correlated with increased tumor cell proliferation. Additionally, syndecan-4 has been shown to enhance β1 integrin function and can trigger signalling cascades required for cell spreading either by exposing a cryptic binding site for β1 integrins or by modulating the activity of β1 integrins. The molecular mechanism required for syndecan-β1 integrin receptor cross-talk involves syndecan-4 dependent activation of PKCα. 43 This activation process is required for cell spreading. Additional effectors required for cell spreading which are activated downstream of the syndecanintegrin signalling complex and include Rac1 and the lipid kinase, phosphoinositide-3-kinase. Activation of RhoA is required for stress-fiber formation, but not for cell spreading. A disintegrin and metalloproteinase-12 (ADAM-12) has been implicated in the differentiation and fusion of skeletal myoblasts and its expression is dramatically upregulated in a number of carcinomas. It interacts directly with the actin cytoskeleton via α-actinin and contains several Src homology 3 (SH3) binding motifs which have been shown to interact with and stimulate the activity of Src tyrosine kinase and PI-3K. Thus indicating that ADAM-12-syndecan signalling complexes may regulate cell adhesion and migration during the processes of development and metastasis. 44 
CONCLUSION
Syndecans by virtue of their Heparin sulfate chains functionally sense extracellular environments. As co-receptors for cell adhesion, cell proliferation and fate determination molecules and other extracellular signals, they collaborate with 'primary' receptors to control signalling (Figure 2 ). Thus, Syndecan plays an important role in the development of embryogenesis, inflammatory diseases, cancers and infection.
